Fig. 2From: Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort studyLikelihood of achieving ASDAS-inactive disease in the subsequent intervals according to the ASDAS-CRP measured at the 1-year follow-up. ASDAS, Ankylosing Spondylitis Disease Activity Score; axSpA, axial spondyloarthritis; CRP, C-reactive proteinBack to article page